Afuco™ Anti-Human NTRK1 ADCC Therapeutic Antibody (MNAC13), ADCC Enhanced
Anti-NTRK1 ADCC Enhanced Antibody (MNAC13) is an ADCC enhanced antibody produced by our Afuco™ platform. MNAC13 is a mouse monoclonal antibody which recognizes the neurotrophin receptor TrkA with high affinity and specificity. It displays a neutralizing activity toward the NGF/TrkA interaction. A full biochemical and structural characterization of the MNAC13 antibody may be appropriate for therapeutic approaches in neuropathy and inflammatory pain states.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-668CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | NTRK1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |